Evidence map›Paper›PMID 33121175›Full record

ArticlePharmaceutics2020

Development of a Curcumin-Loaded Polymeric Microparticulate Oral Drug Delivery System for Colon Targeting by Quality-by-Design Approach.

Dana Hales, Lucia Ruxandra Tefas, Ioan Tomuță, Cristian Moldovan, Diana Gulei, Raluca Munteanu, Alina Porfire

Open access · goldAbstract read
In one paragraph

Article in Pharmaceutics, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 6 papers.

0numbers the graph read from it
0cells of the map it votes in
6citing papers in PubMed
1.1field-weighted citation impact, top 26% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

6 citing papers in PubMed, 23 citations in OpenAlex.

  1. Review
  2. Development of modular polymeric nanoparticles for drug delivery using amine reactive chemistry.Journal of pharmacy & pharmaceutical sciences : a publication of the Canadian Society for Pharmaceutical Sciences, Societe canadienne des sciences pharmaceutiques · 2024
    Article
  3. Review
  4. Article
  5. Article
  6. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors at 1 institution in 1 country.

Dana HalesDepartment of Pharmaceutical Technology and Biopharmacy, Faculty of Pharmacy, University of Medicine and Pharmacy "Iuliu Haţieganu", 41 Victor Babeș Street, 400012 Cluj-Napoca, Romania.
Lucia Ruxandra TefasDepartment of Pharmaceutical Technology and Biopharmacy, Faculty of Pharmacy, University of Medicine and Pharmacy "Iuliu Haţieganu", 41 Victor Babeș Street, 400012 Cluj-Napoca, Romania.
Ioan TomuțăDepartment of Pharmaceutical Technology and Biopharmacy, Faculty of Pharmacy, University of Medicine and Pharmacy "Iuliu Haţieganu", 41 Victor Babeș Street, 400012 Cluj-Napoca, Romania.
Cristian MoldovanResearch Center for Advanced Medicine-MedFUTURE, University of Medicine and Pharmacy "Iuliu Haţieganu", 4-6 L. Pasteur Street, 400349 Cluj-Napoca, Romania.
Diana GuleiResearch Center for Advanced Medicine-MedFUTURE, University of Medicine and Pharmacy "Iuliu Haţieganu", 4-6 L. Pasteur Street, 400349 Cluj-Napoca, Romania.
Raluca MunteanuResearch Center for Advanced Medicine-MedFUTURE, University of Medicine and Pharmacy "Iuliu Haţieganu", 4-6 L. Pasteur Street, 400349 Cluj-Napoca, Romania.
Alina PorfireDepartment of Pharmaceutical Technology and Biopharmacy, Faculty of Pharmacy, University of Medicine and Pharmacy "Iuliu Haţieganu", 41 Victor Babeș Street, 400012 Cluj-Napoca, Romania.
Iuliu Hațieganu University of Medicine and Pharmacy · RO

Funding

European Social Found, Human Capital Operational Programme 2014-2020 POCU/380/6/13/125171
6 · The paper itself

Abstract

The purpose of this study was to apply the quality-by-design (QbD) approach for the development of colon-targeted curcumin-loaded polymeric microparticles (Col-CUR-MPs). The proportion of the enterosoluble polymer (Eudragit

Indexed as

colon-specific deliverycurcuminEudragit® FSmicrospherespolycaprolactonequality-by-design

Identifiers

PMID33121175
PMCPMC7693510
OpenAlexW3097791310

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.